Hakumei Oh

1.5k total citations · 1 hit paper
15 papers, 1.1k citations indexed

About

Hakumei Oh is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Hakumei Oh has authored 15 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Hakumei Oh's work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Hakumei Oh is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Hakumei Oh collaborates with scholars based in Japan, United States and Kenya. Hakumei Oh's co-authors include Ryuzo Ohno, Kenji Saito, Norio Asou, Shuichi Miyawaki, Saburo Minami, Hitoshi Kiyoi, Hideki Akiyama, Ryuzo Ueda, Kazutaka Kuriyama and Chihiro Shimazaki and has published in prestigious journals such as New England Journal of Medicine, Blood and Molecular and Cellular Biology.

In The Last Decade

Hakumei Oh

15 papers receiving 1.0k citations

Hit Papers

Prognostic implication of FLT3 and N-RAS gene mutations i... 1999 2026 2008 2017 1999 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hakumei Oh Japan 8 849 363 305 221 213 15 1.1k
Richard E. Helmer United States 6 851 1.0× 694 1.9× 140 0.5× 269 1.2× 188 0.9× 9 1.3k
Javier Fernández‐Calvo Spain 15 952 1.1× 643 1.8× 298 1.0× 321 1.5× 180 0.8× 24 1.1k
Tomas Ahlgren Sweden 17 967 1.1× 353 1.0× 152 0.5× 436 2.0× 253 1.2× 31 1.3k
S. Faderl United States 16 882 1.0× 417 1.1× 240 0.8× 393 1.8× 214 1.0× 24 1.2k
JR Testa United States 15 1.0k 1.2× 541 1.5× 104 0.3× 238 1.1× 414 1.9× 27 1.3k
M Tribalto Italy 18 1.0k 1.2× 629 1.7× 515 1.7× 237 1.1× 203 1.0× 47 1.3k
Eros Di Bona Italy 17 835 1.0× 394 1.1× 169 0.6× 184 0.8× 431 2.0× 46 1.1k
M. Schmidt United States 7 1.1k 1.3× 460 1.3× 137 0.4× 548 2.5× 141 0.7× 10 1.3k
MM Oken United States 12 587 0.7× 349 1.0× 246 0.8× 146 0.7× 106 0.5× 15 797
Agapi Parcharidou Greece 13 782 0.9× 450 1.2× 242 0.8× 199 0.9× 56 0.3× 20 1.0k

Countries citing papers authored by Hakumei Oh

Since Specialization
Citations

This map shows the geographic impact of Hakumei Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakumei Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakumei Oh more than expected).

Fields of papers citing papers by Hakumei Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakumei Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakumei Oh. The network helps show where Hakumei Oh may publish in the future.

Co-authorship network of co-authors of Hakumei Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Hakumei Oh. A scholar is included among the top collaborators of Hakumei Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakumei Oh. Hakumei Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ohashi, Kazuteru, Juichi Tanabe, Reiko Watanabe, et al.. (2000). The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno‐occlusive disease after stem cell transplantation. American Journal of Hematology. 64(1). 32–38. 4 indexed citations
2.
Ohashi, Kazuteru, Juichi Tanabe, Reiko Watanabe, et al.. (2000). The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation. American Journal of Hematology. 64(1). 32–38. 98 indexed citations
3.
Kiyoi, Hitoshi, Tomoki Naoe, Yasuyuki Nakano, et al.. (1999). Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.. Blood. 93(9). 3074–80. 620 indexed citations breakdown →
4.
Ishii, Hideshi, et al.. (1997). Retinoblastoma protein expressed in human non-Hodgkin's lymphoma cells generates resistance against radiation-induced apoptosis. American Journal of Hematology. 55(1). 46–48. 13 indexed citations
5.
Nakaseko, Chiaki, et al.. (1996). Signalling defect in FMLP‐induced neutrophil respiratory burst in myelodysplastic syndromes. British Journal of Haematology. 95(3). 482–488. 4 indexed citations
6.
Ishii, Hideshi, Teruhiko Yoshida, Hakumei Oh, Sho Yoshida, & Masaaki Terada. (1995). A Truncated K-sam Product Lacking the Distal Carboxyl-Terminal Portion Provides a Reduced Level of Autophosphorylation and Greater Resistance against Induction of Differentiation. Molecular and Cellular Biology. 15(7). 3664–3671. 21 indexed citations
8.
Matsushita, Kazuyuki, Kenji Oda, T. H. Lee, et al.. (1994). Two autopsy cases of Epstein-Barr virus infected T-cell lymphoma preseting as hemophagocytic syndrome.. 34(1). 43–52. 2 indexed citations
9.
Wakita, Hisashi, Takayoshi Asai, Hakumei Oh, Kuniaki Itoh, & Sho Yoshida. (1993). Chemiluminescence of Neutrophils in Patients with Myeloproliferative or Myelodysplastic Hematologic Diseases. Relation to Neutrophil Alkaline Phosphatase Activity.. Internal Medicine. 32(3). 204–209. 5 indexed citations
10.
Baba, Norio, et al.. (1993). The Crystal Structure of Specific Granules in Human Eosinophils Studied by Thin Sectioning and Deep-Etching with the Aid of Fourier Transformation. Journal of Electron Microscopy. 42(3). 172–7. 2 indexed citations
11.
Ishii, Hideshi, Hakumei Oh, Yoshitaka Uchida, et al.. (1992). Effect of Interferon(IFN) on Refractory Idiopathic Thrombocytopenic Purpura: Administration of 6 Million Units of Recombinant IFN alpha-2b.. Internal Medicine. 31(12). 1343–1347. 7 indexed citations
12.
Ohno, Ryuzo, Masao Tomonaga, Tohru Kobayashi, et al.. (1990). Effect of Granulocyte Colony-Stimulating Factor after Intensive Induction Therapy in Relapsed or Refractory Acute Leukemia. New England Journal of Medicine. 323(13). 871–877. 281 indexed citations
13.
Wakita, Hisashi, Takayoshi Asai, Akira Hirasawa, et al.. (1989). Treatment with gabexate mesilate for interstitial pneumonia after bone marrow transplantation.. Ensho. 9(6). 463–467. 1 indexed citations
14.
Masuda, Sonoko, et al.. (1989). Bone marrow and serum concentrations of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D, and 1.ALPHA.,25-dihydroxyvitamin D in patients with leukemia and normal subjects.. Journal of Nutritional Science and Vitaminology. 35(4). 211–223. 7 indexed citations
15.
Asai, Takayoshi, Hisashi Wakita, Yoko Nakajima, et al.. (1988). Red blood cell type changes accompanied with leukemia and glycosyl transferases.. Journal of the Japan Society of Blood Transfusion. 34(5). 505–512. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026